Dietary Fiber: Is it the Missing Link in Achieving Long Term Behavior Change?
- Conditions
- Obesity
- Registration Number
- NCT06227494
- Lead Sponsor
- Oklahoma State University
- Brief Summary
The overall objective of this three-arm randomized controlled trial is to compare a dietary fiber-focused behavioral intervention to standard weight loss education for improving eating-related behavior and cognition, weight, and metabolic markers of chronic disease risk in a population of adults with obesity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 63
- 18-65 years of age
- Dietary fiber intake ≤25 grams/day
- Self-reported BMI ≥30 kg/m2
- Willingness to attend in-person education sessions
- Willingness to avoid taking supplemental digestive aids (e.g., alpha-galactosidase (Beano®),
- Willingness to provide informed consent.
- Metabolic, digestive, or allergic conditions or reactions that preclude consumption of whole food or food groups (e.g., irritable bowel syndrome, diverticulosis)
- History of gastric bypass surgery
- Currently taking glucagon like glucagon-like peptide-1 (GLP-1) Receptor Agonists
- Self-reported history of a diagnosed eating disorder
- Chronic disease (other than obesity)
- Pregnancy or lactation
- Use of tobacco or electronic smoking products
- Taking a pre-, pro-, or syn-biotic supplement
- Enrollment in another weight loss or diet intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Body weight Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Measure of body weight/mass
- Secondary Outcome Measures
Name Time Method Total Cholesterol Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Measured via blood samples (unit= milligram/deciliter (mg/dL))
Fecal bacteria measured using 16S ribosomal ribonucleic acid (rRNA) sequencing Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Will include measures of diversity, abundance, etc.
Fasting blood glucose Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 33, month 27) Measured via blood samples (unit=mg/dL)
Executive Function: Tower Test (Delis-Kaplan Executive Function System) Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Total Achievement Score (range=0-30, higher = higher executive function)
Low-density lipoprotein (LDL) cholesterol Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Measured via blood samples (unit=mg/dL)
Body composition (fat mass, lean mass) Measured at baseline (time 1, month 0) and post-observation (time 3, month 27) Dual x-ray absorptiometry (DEXA) scans
Three-Factor Eating Questionnaire Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Resulting scores in uncontrolled eating (range=9-36), cognitive restraint (range=3-12), and emotional eating (range=6-24); higher scores indicate more of that particular eating behavior
Implicit Association Test Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Represented with a total D variable (No range, but more negative = greater preference for unprocessed food)
Behavioral Inhibition System/Behavioral Approach System (BIS/BAS) Scale Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Score ranges from 20 to 80, with higher scores indicating greater behavioral inhibition and behavioral activation
Executive Function: Color-Word Interference Test (Delis-Kaplan Executive Function System) Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Scaled inhibition/switching scores (score range=1-19, higher = higher executive function)
Skin Carotenoid scores measured via the Veggie Meter Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Veggie Meter; score range 0-800 (higher=greater skin carotenoids (i.e., consumption of more fruits/vegetables)
High-density lipoprotein (HDL) cholesterol Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Measured via blood samples (unit=mg/dL)
Fecal short chain fatty acids Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Taken from fecal samples collected at home
Healthy Eating Index Scores measured using Health Eating Index 2020 (HEI-2020) Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27) Taken from 3 day diet records (score range=0-100, higher=better diet quality)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Oklahoma State University
🇺🇸Stillwater, Oklahoma, United States
Oklahoma State University🇺🇸Stillwater, Oklahoma, United States